CIK 0001326110
- Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 431979754
- Phone
- +1 844-696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- 4 Open-market sale See remarks sold 75,000 shares at $7.56 ($567,338)
- 4 Open-market sale See remarks sold 36,932 shares at $5.52 ($203,698)
- 4 Open-market sale See remarks sold 28,068 shares at $5.50 ($154,509)
- 4 Shares withheld for taxes Chief Financial Officer gave up 6,132 shares (to pay taxes)
- 4 Open-market sale Director sold 30,000 shares at an average $2.87 ($86,000)
- 4 Open-market sale Director sold 10,000 shares at $1.99 ($19,918)
- 4 Open-market sale Director sold 24,000 shares at an average $1.24 ($29,790)
- 4 Shares withheld for taxes Chief Financial Officer gave up 3,458 shares (to pay taxes)
- 4 Grant or award Director acquired 92,592 shares (grant or award)
- 4 Grant or award Director acquired 92,592 shares (grant or award)
- 4 Grant or award Director acquired 92,592 shares (grant or award)
- 4 Grant or award Director acquired 300,925 shares (grant or award)
- 4 Grant or award Director acquired 92,592 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition Chairman and CEO acquired 17,589,250 shares (code O)
- 4 Open-market sale Director sold 138,349 shares at $1.65 ($228,276)
- 4 Open-market sale Director sold 151,159 shares at an average $1.74 ($263,110)
- 4 Open-market sale Director sold 32,212 shares at an average $2.02 ($64,934)
- 4 Open-market sale Director sold 196,280 shares at an average $2.29 ($450,068)
- 4 Derivatives Options or other derivatives
Page 9 of 13 · 251 filings